August 26, 2026 23:58 ET  | Source: Junshi Biosciences SHANGHAI, Aug. 26, 2026 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its 2026 interim financial results and provided corporate updates. FINANCIAL HIGHLIGHTS BUSINESS HIGHLIGHTS During […]

August 26, 2026 09:03 ET  | Source: Royal Philips August 26, 2026               Cambridge, MA, USA and Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has received an up to US$33.7 million award under the Advanced Research Projects Agency for Health (ARPA-H, an agency within the U.S. Department of

August 25, 2026 10:23 ET  | Source: Zymeworks Inc. VANCOUVER, British Columbia, Aug. 25, 2026 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel, multifunctional biotherapeutics, today announced that its partner, Jazz Pharmaceuticals, has received U.S. Food and Drug Administration (FDA) approval

August 24, 2026 17:05 ET  | Source: Royal Philips August 24, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the successful pricing of its offering of EUR 650 million fixed rate notes due 2034 (the “Notes”) under its European Medium Term Note (EMTN) program. The Notes are the

August 21, 2026 09:28 ET  | Source: Allwyn The F1® Allwyn Global Community Award 2026 trophy presented to Monique Maks (Director) and Ronald de Boer (former footballer and ambassador) of winning local charity Spieren voor Spieren at the FORMULA 1® HEINEKEN DUTCH GRAND PRIX 2026 in the Netherlands. The F1® Allwyn Global Community Award 2026 trophy presented to

August 20, 2026 08:00 ET  | Source: Adagene Inc. SAN DIEGO and SUZHOU, China, Aug. 20, 2026 (GLOBE NEWSWIRE) — Adagene Inc.  (Nasdaq: ADAG) a platform-driven, clinical-stage biotechnology company transforming the discovery and development of novel antibody-based therapies, today announced that senior management will participate in three upcoming investor conferences taking place in New York, New York.

August 19, 2026 08:30 ET  | Source: Teva Pharmaceutical Industries Ltd PARSIPPANY, N.J. and TEL AVIV, Israel, Aug. 19, 2026 (GLOBE NEWSWIRE) — Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced that the U.S. Food and Drug Administration (FDA) accepted the New Drug Application (NDA) for ecopipam, with a

August 18, 2026 16:00 ET  | Source: Oil-Dri Corporation Of America CHICAGO, Aug. 18, 2026 (GLOBE NEWSWIRE) — Amlan International, the animal health business of Oil-Dri Corporation of America, will serve as the Technical Symposium Sponsor at the 2026 Arkansas Nutrition Conference in Little Rock, Arkansas. The Amlan-sponsored symposium will take place Tuesday, August 25, from 1:00–5:00

August 18, 2026 03:01 ET  | Source: Smith & Nephew UK Ltd Marking a new approach to innovation in medical robotics, the new centre will bring advances from a leading surgical robotics research group to patients more quickly Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, and Imperial College London have launched a five-year partnership to deliver

Launching with a $4 million Seed round led by Founders Fund, GAMGEE is bringing personalized cancer care to dogs August 17, 2026 15:00 ET  | Source: GAMGEE A Media Snippet accompanying this announcement is available by clicking on this link. SYDNEY, Aug. 17, 2026 (GLOBE NEWSWIRE) — Rosie was given only months to live. Her owner, Paul

August 17, 2026 08:00 ET  | Source: Smith & Nephew UK Ltd Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces a breakthrough in RF resection technology for hip with its new FLOW FLEXTEND COBLATION Wand. Designed as an extension of its proprietary FLOW~IQ◊ technology with an adjustable-angle tip, the FLOW FLEXTEND Wand is designed to give

August 14, 2026 16:55 ET  | Source: Optimi Health Corp. VANCOUVER, British Columbia, Aug. 14, 2026 (GLOBE NEWSWIRE) — Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) (the “Company” or “Optimi”), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today announced that it has entered into a common shares purchase agreement (the “Purchase Agreement”) with

August 12, 2026 07:30 ET  | Source: Adagene Inc. Randomized Phase 2 trial in microsatellite stable colorectal cancer (MSS CRC) ongoing, with results expected in 1H 2027; potential registration trial expected in 2027 once recommended dose regimen has been established  Data reported at AACR from triple combination therapy in 1L hepatocellular carcinoma (HCC) and late-line MSS CRC

August 11, 2026 15:47 ET  | Source: Egg Medical, Inc. ST. PAUL, Minn., Aug. 11, 2026 (GLOBE NEWSWIRE) — Egg Medical announced today that Rampart IC, LLC (“Rampart”) withdrew its appeal of the USPTO’s reexamination decision that the claims of Rampart’s U.S. Patent No. 11, 660,056 as originally granted were invalid. The USPTO’s invalidation is based on grounds that

August 11, 2026 08:00 ET  | Source: Teva Pharmaceutical Industries Ltd TEL AVIV, Israel, Aug. 11, 2026 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Moody’s Ratings has upgraded Teva’s corporate credit rating to Baa3 from Ba1, an investment-grade rating, with a stable outlook.  Moody’s states that the upgrade reflects the